These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 4619608)

  • 21. [Von Willebrand's disease. Studies on platelet function, ristocetin induced platelet aggregation and factor VIII related antigen (author's transl)].
    Mimaya J; Nagao T; Iizuka A; Yamashita H
    Rinsho Ketsueki; 1975 Aug; 16(8):775-84. PubMed ID: 1081150
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
    Gralnick HR; Coller BS; Sultan Y
    J Clin Invest; 1975 Oct; 56(4):814-27. PubMed ID: 1080491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Functional significance of intra-platelet factor VIII-related antigen].
    Grignani G; Piovella F; Malamani GD; Cattaneo G
    Boll Soc Ital Biol Sper; 1977 Sep; 53(17):1489-94. PubMed ID: 75736
    [No Abstract]   [Full Text] [Related]  

  • 24. Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease.
    Barbui T; Dini E
    Acta Haematol; 1975; 53(1):44-8. PubMed ID: 807074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Coagulation factors and blood platelets. (Presence and location of factor VIII and of fibrinogen in normal human platelets and in patients with coagulation disorders, using an immunofluorescence technic)].
    Fabris F; Betterle C; Casonato A; De Marco L; Girolami A
    Ric Clin Lab; 1979; 9(2 Suppl):51-63. PubMed ID: 395621
    [No Abstract]   [Full Text] [Related]  

  • 26. [Development of a competitive enzyme immunoassay for factor VIII-related antigen].
    Riemer J; Kopperschläger G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(1):72-83. PubMed ID: 6202602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinguishing mild hemophilia A from von Willebrand's syndrome.
    Sabo MG; Triplett DA; Peden JC
    Am J Med Technol; 1978 May; 44(5):455-63. PubMed ID: 307909
    [No Abstract]   [Full Text] [Related]  

  • 28. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor VIII related antigen in platelets from patients with von Willebrand's disease: a study of eight cases.
    Piovella F; Majolino I; Nalli G; Sitar GM; Cattaneo G; Malamani GD; Ascari E
    Haematologica; 1976 Jun; 61(2):194-201. PubMed ID: 820607
    [No Abstract]   [Full Text] [Related]  

  • 30. Evidence that factor VIII and the ristocetin aggregating factor (VIIIRist) are separate molecular entities.
    Hougie C; Sargeant RB; Brown JE; Baugh RF
    Proc Soc Exp Biol Med; 1974 Oct; 147(1):58-61. PubMed ID: 4548194
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on the relationship between factor VIII related antigen (VIIIRAg) and factor VIII clotting antigen (VIIICAg) by immunoelectrophoresis and autoradiography using 125I anti VIIICAg.
    Davies BL; Furlong RA; Peake IR
    Thromb Res; 1981 Apr 1-15; 22(1-2):87-96. PubMed ID: 6794178
    [No Abstract]   [Full Text] [Related]  

  • 32. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelets and factor VIII in von Willebrand's disease.
    Green D; Potter EV
    N Engl J Med; 1977 Jun; 296(23):1357. PubMed ID: 300843
    [No Abstract]   [Full Text] [Related]  

  • 34. The identification and functional significance of factor VIII components on normal platelets.
    Flaum MA; Donlon JA; Gralnick HR; Rick ME
    Thromb Res; 1982 May; 26(3):165-75. PubMed ID: 6810495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simplified method for the production of heterologous antiserum to factor VIII related antigen.
    Yang HC; Duffy C; Levine PH
    Thromb Res; 1977 Oct; 11(4):463-70. PubMed ID: 411194
    [No Abstract]   [Full Text] [Related]  

  • 36. [Molecular defect in hemophilia and von Willebrand's disease (author's transl)].
    Fukui H
    Rinsho Byori; 1976 Apr; 24(4):274-8. PubMed ID: 1084430
    [No Abstract]   [Full Text] [Related]  

  • 37. Antibody-induced von Willebrand syndrome: inhibition of VIII VWF and VIII AGN with sparing of VIII AHF by the autoantibody.
    Gazengel C; Prieur AM; Jacques C; Buriot D; Nedellec J; Josso F
    Am J Hematol; 1978; 5(4):355-63. PubMed ID: 313704
    [No Abstract]   [Full Text] [Related]  

  • 38. The immunological properties of factor VIII. I. Studies on the inhibitory activity of specific antisera to human antihemophilic globulin.
    Uszyński L
    Thromb Diath Haemorrh; 1966 Dec; 16(3):558-73. PubMed ID: 5301276
    [No Abstract]   [Full Text] [Related]  

  • 39. Theoretical approach to molecular biology of factor VIII: heterogeneity of the molecule.
    Gralnick HR; Marchesi SL; Coller BS
    Ann N Y Acad Sci; 1975 Jan; 240():378-88. PubMed ID: 1078621
    [No Abstract]   [Full Text] [Related]  

  • 40. Von Willebrand's disease.
    Zimmerman TS; Ruggeri ZM
    Prog Hemost Thromb; 1982; 6():203-36. PubMed ID: 6820163
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.